Origin Asset Management LLP Regeneron Pharmaceuticals, Inc. Transaction History

Origin Asset Management LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $1.49 Million - $1.77 Million	-2,600 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $44,673 - $54,820	-100 Reduced 3.7%	2,600 $1.23 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $435,800 - $526,568	-800 Reduced 22.86%	2,700 $1.51 Million
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $147,996 - $193,176	-300 Reduced 7.89%	3,500 $2.18 Million
Q1 2020 May 05, 2020	BUY	$336.18 - $494.43 $1.28 Million - $1.88 Million	3,800 New	3,800 $1.86 Million
Q2 2019 Aug 09, 2019	SELL	$299.6 - $414.82 $16.3 Million - $22.5 Million	-54,250 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $6.33 Million - $7.47 Million	17,000 Added 45.64%	54,250 $22.3 Million
Q4 2018 Feb 12, 2019	BUY	$335.82 - $403.04 $352,611 - $423,192	1,050 Added 2.9%	37,250 $13.9 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $12.7 Million - $14.8 Million	36,200 New	36,200 $14.6 Million

1,532

82.7M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $78.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Origin Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Origin Asset Management LLP with notifications on news.